Details of the Drug Combinations

General Information of This Drug (ID: DMULZ4W)

Drug Name

CHR-2797 DMULZ4W

Synonyms

Tosedostat; Tosedostat, CHR2797, CHR-2797

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 2	[1]
Myelodysplastic syndrome	2A37	Phase 2	[2]
Inflammation	1A00-CA43.1	Terminated	[3]
------------------------------------------------------------------------------------

Therapeutic Class

Anticancer Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Capecitabine + CHR-2797	DC0FV9N	Capecitabine	Pancreatic Cancer	[4]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022187)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014340)
4	ClinicalTrials.gov (NCT02352831) Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma